MIP-4 Antibodies

Santa Cruz Biotechnology delivers a wide array of MIP-4 monoclonal antibodies for research focused on understanding this important chemokine. MIP-4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MIP-4, also known as CCL18, is a chemokine that recruits immune cells to sites of inflammation and maintains tissue homeostasis. MIP-4 expression patterns have been linked to various pathological conditions, including cancer and autoimmune diseases, highlighting its significance as a therapeutic target and biomarker. Understanding MIP-4 function provides valuable insights into disease mechanisms and potential treatment approaches. Researchers investigating immune system regulation can utilize MIP-4 monoclonal antibodies to advance their studies in cellular signaling pathways. The high specificity of MIP-4 monoclonal antibodies enables precise detection and characterization of protein expression patterns across different tissue types. Ongoing research with MIP-4 monoclonal antibodies continues to reveal new aspects of immune cell recruitment and inflammatory responses. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of immune system regulation and disease mechanisms.